Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to CRM1 https://t.co/faBTA0d4m7
Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to CRM1.
Mentions
Extended reach
Total likes
Video views
Mentions per month
May 2023 – Aug 2023Where it's discussed
-
X / Twitter1 posts
-
YouTube1 videos
AI synopsis
What people are saying
The discussions highlight the importance of BATF2's role in colorectal cancer, with posts referencing its export via CRM1 and its effect on cell proliferation, using phrases like 'key to understanding cancer growth' and 'potential therapeutic target'. The tone varies from analytical to cautiously optimistic, reflecting a balanced view of the study's significance.
Most discussions acknowledge the significance of the research, although some express cautious optimism or mild skepticism about its implications.
The social discussions reflect a moderate curiosity, with participants interested in how BATF2 influences cancer progression and potential therapies.
Comments often delve into the biological mechanisms, indicating active engagement, but few elaborate extensively on the broader impact.
Participants generally recognize the research as important but do not underscore it as a groundbreaking shift, suggesting a moderate view of its influence.
Abstract in brief
- The study reveals that BATF2, a tumor suppressor, is mainly located in the cytoplasm of colorectal cancer (CRC) cells, and its cytoplasmic presence is linked to poorer patient prognosis.
- BATF2 is exported from the nucleus to the cytoplasm via binding to CRM1, a process that involves a specific nuclear export sequence (NES) in BATF2, leading to its degradation and promoting cancer cell growth.
- The enhanced export of BATF2 out of the nucleus activates pathways like activator protein 1 (AP1) and cyclin D1, which drive cell proliferation through the phosphorylation of retinoblastoma protein (pRb), thereby supporting CRC progression.
Top posts
Most liked on X and BlueskyAll mentions
Nuclear Export of BATF2 Promotes Colorectal Cancer Growth via CRM1 Binding
The study reveals that BATF2, a tumor suppressor, is mainly located in the cytoplasm of colorectal cancer cells, and its cytoplasmic presence is linked to poorer patient prognosis. BATF2's export from the nucleus to the…
Nuclear export of BATF2 enhances colorectal cancer proliferation through binding to CRM1 https://t.co/faBTA0d4m7